PGE2 leads to down-regulation of RIPK3, which in turn results in induction of COX-2 and increased production of PGE2 by the MDSCs, which in turn increases proliferation of cancer cells and inhibits the anti-tumor function of CD8+ T cells. The gene discussed is RIPK3; the disease is neoplasm.